Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is trading at $36.16, about ₹3,503 at today's USD/INR rate, as of 8 Oct 2026, 4:00 PM ET, down 0.69% today. Indian residents can buy Xenon Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$35.06
Today's high
$36.34
52 week low
$35.06
52 week high
$72.66
XENE opened at $36.00, closed previously at $36.41, and has traded between $35.06 and $72.66 over the past 52 weeks.
About
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activator of Kv7 potassium channels, is currently in Phase III clinical trials for KCNQ2 developmental and epileptic encephalopathy. Another Kv7 potassium channel activator, XEN1101, is progressing through Phase II trials, targeting epilepsy and a range of other neurological conditions. The portfolio also includes NBI-921352, a selective inhibitor of the Nav1.6 sodium channel, which is undergoing Phase II clinical evaluation for SCN8A developmental and epileptic encephalopathy, alongside investigations for adult focal epilepsy and other potential indications. Furthermore, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase II development. Beyond its internal development, Xenon Pharmaceuticals has established strategic collaborations. This includes a licensing and development agreement with Neurocrine Biosciences, Inc. focused on epilepsy treatments, and a partnership with Flexion Therapeutics, Inc. to advance PCRX301 (also known as XEN402), a Nav1.7 inhibitor, for post-operative pain management. Established in 1996, the company continues its mission to address significant unmet medical needs in neurology.
Key statistics
Avg. volume
1.54M
Market cap
$3.50B
P/E Ratio
-7.63
Price-to-sales ratio
0.00
Enterprise value
$3.36B
Free cash flow yield
-7.88%
Debt-to-equity ratio
0.01
Return on equity
-59.46%
ROIC
-39.63%
Beta
0.60
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$7.50M
Earnings per share
-$4.36
Free cash flow
-$279.92M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$342.35M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy Xenon Pharmaceuticals from India
Indian residents can buy Xenon Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Xenon Pharmaceuticals from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Xenon Pharmaceuticals and place an order
Find Xenon Pharmaceuticals by name or by its ticker, XENE, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Xenon Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Xenon Pharmaceuticals position in USD and INR. Xenon Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying Xenon Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneXenon Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can Indian residents buy Xenon Pharmaceuticals stock?
Yes. Xenon Pharmaceuticals (XENE) has been listed on NASDAQ since 2014, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Xenon Pharmaceuticals share cost in rupees?
One Xenon Pharmaceuticals share is $36.16 — about ₹3,503 at a USD/INR rate of 96.88 on 8 Oct 2026. Both the Xenon Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Xenon Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Xenon Pharmaceuticals?
Yes. One Xenon Pharmaceuticals share is $36.16, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Xenon Pharmaceuticals.
How are gains on Xenon Pharmaceuticals shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Xenon Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Xenon Pharmaceuticals pay a dividend?
No. Xenon Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Xenon Pharmaceuticals from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Xenon Pharmaceuticals a United States company, and does that change how it is taxed?
Xenon Pharmaceuticals trades on NASDAQ in US dollars, but the company is domiciled in Canada. Xenon Pharmaceuticals trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Xenon Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Xenon Pharmaceuticals holding, its cost and its closing value.
How do I sell Xenon Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.